Vilnius, Lithuania & Limassol, Cyprus—March 3, 2026—The German Medical Institute has selected Oxipit as its chest X-ray AI partner following a structured clinical evaluation of three leading vendors across more than 700 real-world cases. The assessment focused on clinical reliability, workflow integration, reporting efficiency and practical usability in daily radiology operations. Oxipit was chosen to support pathology detection (CAD), smart triage, and semi-autonomous pre-populated reports—all integrated directly into the PACS workflow via the Newton's Tree platform.

Oxipit announces the launch of CT Eye™ and MSK Eye™, two new CE-certified AI solutions expanding its radiology AI portfolio beyond chest X-ray into chest CT and musculoskeletal X-ray workflows. Oxipit will demonstrate these solutions at the European Congress of Radiology (ECR) 2026 this March, alongside its globally adopted CXR Suite, known for introducing the world’s only autonomous healthy chest X-ray reporting solution.

Vilnius, Lithuania – November 18, 2025 – Oxipit, a leading provider of AI-driven medical imaging solutions, announced that Diagnostikum Group, one of Austria’s foremost diagnostic providers, has chosen the Oxipit CXR Suite to enhance chest X-ray workflows across its network. The implementation will take place through Oxipit’s partner DeepC, ensuring seamless integration into Diagnostikum’s existing clinical environment. 

August 19, 2025—Vilnius, Lithuania—Oxipit, a leading AI-driven healthcare technology company, is pleased to announce that Kevin Shah has joined the company as Strategic Advisor, bringing invaluable guidance as the company builds on recent sales momentum and prepares for the launch of its upcoming MSK and CT solutions. His deep market knowledge and proven commercial experience align closely with Oxipit’s mission to lead the future of autonomous radiology—delivering trusted AI solutions that empower equitable, precise healthcare, transform diagnosis, and improve patient care worldwide. 

At Šeškinės Poliklinika, one of Lithuania’s largest public clinics, radiologists process over 2,700 chest X-rays each month. To meet rising demand without compromising care, the clinic implemented the Oxipit CXR Suite—a portfolio of AI tools built for chest X-ray workflows. Today, Oxipit’s AI autonomously reports up to 80% of routine, healthy chest X-rays, allowing radiologists to focus on more complex cases. Integrated real-time quality assurance adds a second layer of diagnostic safety, supporting confident, consistent decisions. This case study explores how the clinic moved from early adoption to measurable results—with faster reporting, reduced workload, and AI now fully embedded in everyday practice.

Bærum, Norway – June 5, 2025 – Oxipit, a leading provider of AI-driven medical imaging solutions, announced the collaboration with Vestre Viken Health Trust in launching Norway's first pilot project for AI-powered thoracic (lung) X-ray imaging. This initiative will evaluate ChestLink, the world’s first autonomous AI tool for reporting normal chest X-rays.

FIDI (Fundação Instituto de Pesquisa e Estudo de Diagnóstico por Imagem) is one of Latin America's largest radiology service providers, delivering more than 400,000 diagnostic studies each month across 90 sites in Brazil. In 2024, FIDI introduced Oxipit’s AI-powered chest X-ray support tool in emergency departments, where fast, consistent interpretation is critical and real-time radiologist input is not always available.

February 27, 2025 — Vilnius, Lithuania — Oxipit, a leading AI-driven healthcare technology company, has announced the appointment of Dr. Robert Epstein to its Radiology Advisory Board. His expertise in radiology and healthcare strategy will support Oxipit’s mission to enhance diagnostic workflows worldwide through trusted AI solutions, enabling faster, more precise diagnoses and advancing patient care.

February 17, 2025 — Geneva, Switzerland — Unilabs, a leading diagnostic services provider in Europe, announced the selection of AI solutions from Oxipit, a pioneering medical imaging AI company, to deploy solutions for chest X-rays throughout Unilabs’ European network. This partnership will see Oxipit’s AI solutions, ChestLink and ChestEye, integrated into Unilabs’ radiology workflows, streamlining chest X-ray reporting through automated triage and second-reading capabilities. The agreement covers the option to use these solutions within the entire Unilabs group in Europe, with the initial rollout starting in Portugal.

Oxipit further expands commercial availability of its solutions via partnership with deepc. This collaboration will integrate Oxipit’s advanced AI solutions - ChestLink, ChestEye, and ChestEye Quality - into the deepcOS platform, delivering effortless access to Oxipit solutions directly within existing Healthcare IT systems, with just one simple integration.